AptarGroup, Inc. (ATR)
NYSE
Price as at 1 Oct 2026, 15:14 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
AptarGroup, Inc. trades at $120.37. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About AptarGroup, Inc.
AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets. The company operates through three segments: Pharma, Beauty, and Closures. It provides dispensing pumps used to dispense sprays, liquids, or lotions from non-pressurized containers; fine-mist pumps for pharmaceutical and fragrance applications; and lotion pumps for viscous formulations, as well as closures, such as dispensing and non-dispensing solutions that enable product delivery without removal of the cap and used across various consumer end markets. The company also offers aerosol valves used in pressurized containers and continuous spray and metered-dose valves for pharmaceutical, personal care, and household applications; elastomeric primary packaging components; active material science solutions; and digital health solutions. The company primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Super investor ownership
10 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- Cliff Asness, AQR CAPITAL MANAGEMENT LLC$84.71M · 0.0% of book
- D. E. Shaw, D. E. Shaw & Co., Inc.$49.13M · 0.0% of book
- Jeremy Grantham, Grantham, Mayo, Van Otterloo & Co. LLC$35.83M · 0.1% of book
- Ken Griffin, CITADEL ADVISORS LLC$30.16M · 0.0% of book
- Renaissance Technologies, RENAISSANCE TECHNOLOGIES LLC$21.33M · 0.0% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
Politician trades in ATR
We hold 14 disclosed trades in ATR by members of Congress and executive-branch officials. The latest 5:
- Michael T. McCaul · HouseSell · $1,001 - $15,000 · traded 18 Jun 2026 · disclosed 8 Jul 2026
- Michael T. McCaul · HouseBuy · $15,001 - $50,000 · traded 12 Jun 2026 · disclosed 8 Jul 2026
- Donald J Trump · Executive branchBuy · $15,001 - $50,000 · traded 22 May 2026 · disclosed 1 Jul 2026
- Donald J Trump · Executive branchSell · $1,001 - $15,000 · traded 28 Apr 2026 · disclosed 1 Jul 2026
- Donald J Trump · Executive branchSell · $1,001 - $15,000 · traded 8 Jul 2024 · disclosed 22 Sept 2026
A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.
Common questions
Which funds own ATR?
10 of the institutions we track reported a position in ATR in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
Where does SteadyShares get its ATR data?
Fundamentals for ATR come from company filings and exchange data, as listed on NYSE; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 15:14 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for ATR, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.